Drug Development Global Program

Prescription for a healthier world

PATH’s Drug Development program is working to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in developing countries. By combining entrepreneurial energy, pharmaceutical expertise, and an innovative product development partnership model, we challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. Find out more »

Diarrhea Innovations Group

Diarrhea Innovations Group launchesAn open source, global network of innovators committed to reducing child deaths from diarrhea by accelerating the development of new tools and approaches in diagnostics, therapeutics, and nutrition. Read more»

Program spotlight

in the news: Addressing Cryptosporidium infection among young children in low-income settings »

fact sheet: Stabilizing the antimalarial drug supply »

infographic: Semisynthetic artemisinin »

on our blog: The crucial role of drugs against Cryptosporidium»

Sign up for our e-newsletter

Our e-newsletter, A Healthy Dose, gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development. Sign up now »

Banner photo: Jonathan Torgovnik.

Comments are closed.